Theseus Pharmaceuticals, Inc. THRX
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL PARTNERS, LP | DELAWARE | 0 | 3101606 | 0 | 3101606 | 3101606 | 7 % | 24/11/2023 |
| Concentra Biosciences, LLC | UNITED STATES | 0 | 0 | 0 | 0 | 0 | 0 % | 24/11/2023 |
| TANG CAPITAL MANAGEMENT, LLC | DELAWARE | 0 | 3101606 | 0 | 3101606 | 3101606 | 7 % | 24/11/2023 |
| KEVIN TANG | UNITED STATES | 0 | 3101606 | 0 | 3101606 | 3101606 | 7 % | 24/11/2023 |
| Foresite Capital Opportunity Management V, LLC (“FCOM V”) | Delaware | 1385825 | 0 | 1385825 | 10 | 1385825 | 3.2 % | 19/07/2023 |
| Foresite Capital Opportunity Fund V, L.P. (“FCOF V”) | Delaware | 1385825 | 0 | 1385825 | 10 | 1385825 | 3.2 % | 19/07/2023 |
| Foresite Capital Management V, LLC (“FCM V”) | Delaware | 4108796 | 0 | 4108796 | 10 | 4108796 | 9.4 % | 19/07/2023 |
| Foresite Capital Fund V, L.P. (“FCF V”) | Delaware | 4108796 | 0 | 4108796 | 10 | 4108796 | 9.4 % | 19/07/2023 |
| James B. Tananbaum (“Tananbaum”) | U.S. Citizen | 5494621 | 0 | 5494621 | 10 | 5494621 | 12.6 % | 19/07/2023 |
| James N. Topper | Delaware | 0 | 2248194 | 0 | 2248194 | 2248194 | 5.8 % | 23/01/2023 |
| Patrick J. Heron | Delaware | 0 | 2248194 | 0 | 2248194 | 2248194 | 5.8 % | 23/01/2023 |
| Albert Cha | Delaware | 0 | 1816541 | 0 | 1816541 | 1816541 | 4.7 % | 23/01/2023 |
| James Brush | Delaware | 0 | 1816541 | 0 | 1816541 | 1816541 | 4.7 % | 23/01/2023 |
| Daniel Estes | Delaware | 0 | 431653 | 0 | 431653 | 431653 | 1.1 % | 23/01/2023 |
| FHMLS XI, L.P. | Delaware | 0 | 431653 | 0 | 431653 | 431653 | 1.1 % | 23/01/2023 |
| FHMLSP, L.P. | Delaware | 0 | 908271 | 0 | 908271 | 908271 | 2.3 % | 23/01/2023 |
| Frazier Life Sciences Public Fund, L.P. | Delaware | 0 | 908271 | 0 | 908271 | 908271 | 2.3 % | 23/01/2023 |
| FHMLSP, L.L.C. | Delaware | 0 | 908271 | 0 | 908271 | 908271 | 2.3 % | 23/01/2023 |
| Frazier Life Sciences Public Overage Fund, L.P. | Delaware | 0 | 908270 | 0 | 908270 | 908270 | 2.3 % | 23/01/2023 |
| FHMLSP Overage, L.P. | Delaware | 0 | 908270 | 0 | 908270 | 908270 | 2.3 % | 23/01/2023 |
| FHMLSP Overage, L.L.C. | Delaware | 0 | 908270 | 0 | 908270 | 908270 | 2.3 % | 23/01/2023 |
| Frazier Life Sciences XI, L.P. | Delaware | 0 | 431653 | 0 | 431653 | 431653 | 1.1 % | 23/01/2023 |
| FHMLS XI, L.L.C. | Delaware | 0 | 431653 | 0 | 431653 | 431653 | 1.1 % | 23/01/2023 |
| Abigail P. Johnson | Delaware | 0 | 0 | 3953716 | 0 | 3953716 | 10.534 % | 10/11/2021 |
| FMR LLC | Delaware | 348899 | 0 | 3953716 | 0 | 3953716 | 10.534 % | 10/11/2021 |
| OrbiMed Genesis GP LLC | Cayman Islands | 0 | 499150 | 0 | 10 | 499150 | 1.3 % | 19/10/2021 |
| OrbiMed Advisors LLC | Delaware | 0 | 16838668 | 0 | 10 | 16838668 | 44.9 % | 19/10/2021 |
| OrbiMed Capital GP VII LLC | Delaware | 0 | 16339518 | 0 | 10 | 16339518 | 43.5 % | 19/10/2021 |
| Capital Fund V, L.P. (“FCF V”) | Delaware | 3212732 | 0 | 3212732 | 0 | 3212732 | 8.6 % | 18/10/2021 |
| Capital Opportunity Fund V, L.P. (“FCOF V”) | OR PLACE OF ORGANIZATION Delaware | 468820 | 0 | 468820 | 0 | 468820 | 1.2 % | 18/10/2021 |
| B. Tananbaum (“Tananbaum”) | OR PLACE OF ORGANIZATION U.S. Citizen | 3681552 | 0 | 3681552 | 0 | 3681552 | 9.8 % | 18/10/2021 |
| Capital Opportunity Management V, LLC (“FCOM V”) | OR PLACE OF ORGANIZATION Delaware | 468820 | 0 | 468820 | 0 | 468820 | 1.2 % | 18/10/2021 |
| Foresite Capital Management V, LLC (“FCM V”) | OR PLACE OF ORGANIZATION Delaware | 3212732 | 0 | 3212732 | 0 | 3212732 | 8.6 % | 18/10/2021 |